tyb
can confirm the "eyes" have it. Not a typical aircraft going in or out
Chair/Pres/CEO sold $10.4m in shares-June 25
Insmed Incorporated is a biopharmaceutical company. The Company operates through development and commercialization of therapies for patients with rare diseases segment. Its lead product candidate is ARIKAYCE, or liposomal amikacin for inhalation (LAI), which is in late-stage development for adult patients with treatment refractory nontuberculous mycobacteria (NTM) lung disease caused by Mycobacterium avium complex (MAC). Its earlier-stage pipeline includes preclinical compounds that the Company is evaluating in multiple rare diseases of unmet medical need, including methicillin-resistant staph aureus and NTM. Its earlier clinical-stage pipeline includes INS1007 and INS1009. INS1007 is an oral, reversible inhibitor of dipeptidyl peptidase 1. INS1009 is an inhaled nanoparticle formulation of a treprostinil prodrug that may offer a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension. It has completed a Phase I study of INS1009.
Number of employees : 214 people.
https://www.marketscreener.com/INSMED-INCORPORATED-9696/company/
https://www.secform4.com/insider-trading/1104506.htm
cap#2
INSMED INC : Other Events, Financial Statements and Exhibits (form 8-K)
As previously announced, Insmed Incorporated (the "Company") and William H. Lewis, Chairman and Chief Executive Officer of the Company (the "Selling Shareholder"), entered into an Underwriting Agreement, dated May 21, 2019 (the "Underwriting Agreement"), with Morgan Stanley & Co. LLC, SVB Leerink LLC and Goldman Sachs & Co. LLC, as managers of the underwriters named in Schedule I thereto (the "Underwriters"), pursuant to which, subject to satisfaction of the conditions set forth therein, (1) the Company agreed to sell to the Underwriters, and the Underwriters agreed to purchase from the Company, 9,615,385 shares (the "Company Firm Shares") of common stock, par value $0.01 per share, of the Company (the "Common Stock"), and (2) the Company granted the Underwriters an option to purchase up to an additional 1,042,307 shares of Common Stock (the "Additional Company Shares") and the Selling Shareholder granted the Underwriters an option to purchase up to 400,000 shares of Common Stock (the "Selling Shareholder Shares," together with the Additional Company Shares, the "Additional Shares"). The Underwriters' options to purchase Additional Shares were exercisable within 30 days after May 21, 2019.
The offering of the Company Firm Shares pursuant to the Underwriting Agreement closed on May 24, 2019. On June 20, 2019, the Underwriters exercised their options to purchase all of the Additional Shares. The net proceeds to the Company from the sale of the Additional Company Shares, after deducting underwriting discounts and commissions but before expenses, are expected to be approximately $25.6 million. The Company will not receive any proceeds from the sale of the Selling Shareholder Shares.
https://www.marketscreener.com/INSMED-INCORPORATED-9696/news/INSMED-INC-Other-Events-Financial-Statements-and-Exhibits-form-8-K-28810253/
>it went from plantation slavery to a financial slavery.
unfortunately we all got on that 'ride'. nice to get off it finally
Freddie Mac: Mortgage Serious Delinquency Rate Decreased in May
Freddie Mac reported that the Single-Family serious delinquency rate in May was 0.63%, down from 0.65% in April. Freddie's rate is down from 0.87% in May 2018.
Freddie's serious delinquency rate peaked in February 2010 at 4.20%.
This is the lowest serious delinquency rate for Freddie Mac since November 2007.
These are mortgage loans that are "three monthly payments or more past due or in foreclosure".
Expect the delinquency rate to decline to a cycle bottom in the 0.4% to 0.6% range - so this is close to a bottom.
https://www.calculatedriskblog.com/2019/06/freddie-mac-mortgage-serious.html?
Wayfair Stock Sales since 2014
Wayfair Inc. (Wayfair) offers browsing, merchandising and product discovery for a range of products from various suppliers. The Company operates through two segments: U.S. and International. The U.S. segment consists of amounts earned through product sales through the Company's five sites in the United States and through sites operated by third parties in the United States. The International segment consists of amounts earned through product sales through its international sites. It has an online selection of furniture, decor, decorative accents, housewares, seasonal decor and other home goods. As of December 31, 2016, it had offered five sites, including Websites, mobile-optimized Websites and mobile applications: Wayfair, Joss & Main, AllModern, DwellStudio and Birch Lane. Wayfair is an online destination for all things home. Birch Lane offers a collection of furnishings and home decor. Its sites feature certain products under its house brands, such as Three Posts and Mercury Row.
Number of employees : 7 751 people.
https://www.marketscreener.com/WAYFAIR-INC-18126549/company/
https://www.secform4.com/insider-trading/1616707.htm
chek't
yep
some may and not say.
that's what makes it all the better. Never see it coming. Can only be that way. There are many naive people so…
o7
not thinking is naive
system knows it's coming, the people who chose to follow them…not so much!